Retatrutide produces weight loss of a magnitude previously seen mainly with bariatric surgery up to a mean of roughly 24% of body weight at 48 weeks in phase 2 obesity data
Using health databases in Finland, Iceland, Norway, Sweden, the United States, and Israel, the researchers examined the outcomes of more than 3.5 million pregnancies between 2009 and 2021
For example, if you started a GLP-1 in September 2024 with a BMI of 37, but in July 2026 you've lost weight and now have a BMI of 34, the prescriber should attest in the prior authorization request that you met the BMI criteria of 35 or over when the GLP-1 therapy started
Respond to urges promptly : Delaying defecation can worsen constipation
Always perform a visual inspection before each use
Here is the full list of who should not take GLP-1 drugs and why